Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain HOLX message board posts where the ticker symbol HOLX has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest HOLX SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-035126 Size: 4 KB
2018-12-04
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-035117 Size: 7 KB
2018-12-04
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-035109 Size: 5 KB
2018-12-04
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-035105 Size: 11 KB
2018-12-04
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-035100 Size: 5 KB
2018-12-04
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-035090 Size: 5 KB
2018-12-04
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-034840 Size: 8 KB
2018-11-30
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-034295 Size: 6 KB
2018-11-26
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001127602-18-034293 Size: 6 KB
2018-11-26
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-033988 Size: 4 KB
2018-11-20
More HOLX SEC Filings


Related news from
Thu, 06 Dec 2018
18:28:13 +0000
How Hologic Stock Has Fared in the Last Month
After rising from $36.53 on April 9, 2018, to $42.91 on July 31, 2018, Hologic (HOLX) stock slid to $37.90 on October 29, 2018. Subsequently, Hologic stock managed to rise to $44.51 on November 28, 2018. Hologic’s revenue grew by 1.32% from $802.9 million in the fourth quarter of 2017 to $813.5 million in the fourth quarter of 2018.
Tue, 04 Dec 2018
13:03:57 +0000
See what the IHS Markit Score report has to say about Hologic Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Fri, 30 Nov 2018
12:39:06 +0000
3 Big Stock Charts for Friday: Hologic, Newell Brands and Juniper Networks
The 2.6% advance from General Electric (NYSE:GE) shares on Thursday still wasn’t enough to get, and keep, the overall market out of the red. Although the index spent some time in profitable territory yesterday, by the time the closing bell rang the S&P 500 was down to the tune of 0.22%. Rather than GE, a few too many traders were taking their cues from Twitter (NYSE:TWTR) and Quest Diagnostics (NYSE:DGX).
Thu, 29 Nov 2018
13:11:05 +0000
Analysts Remain Bullish on Align Stock
In November 2018, of the total 15 analysts covering Align Technology (ALGN), 13 analysts have given Align stock a “buy” or higher rating, and two analysts have given it a “hold” rating. The mean rating for Align Technology stock is 1.67 with a target price of $317.36, implying an upside potential of 43.8% over Align Technology’s closing price of $220.71 on November 27, 2018.
Mon, 26 Nov 2018
14:30:14 +0000
What Analysts Recommend for Hologic Stock
In November 2018, of the total 20 analysts covering Hologic (HOLX), ten analysts have given the stock a “buy” or higher rating, and ten analysts have given it a “hold” rating. The mean rating for Hologic stock is 2.3 with a target price of $45.09, implying an upside potential of 8.5% over Hologic’s closing price of $41.54 on November 21, 2018.
Mon, 26 Nov 2018
14:30:13 +0000
How Does Hologic’s Operational Performance Look?
Hologic (HOLX) incurred general and administrative expenses of $366.1 million in fiscal 2018 as compared with $343.3 million in fiscal 2017. This increase was due to higher legal fees, costs for international infrastructure, and higher bad debt. Its selling and marketing expenses also increased from $498.6 million in fiscal 2017 to $544.6 million in fiscal 2018 due to Cynosure’s inclusion in Hologic’s activity.
Mon, 26 Nov 2018
14:30:13 +0000
A Look at Hologic’s Gross Margin Trend
Hologic’s (HOLX) cost of product revenues increased from $881.8 million in fiscal 2017 to $886.6 million in fiscal 2018. Its amortization on intangible assets increased from $297.1 million in fiscal 2017 to $319.4 million in fiscal 2018 due to an increase associated with the Cynosure acquisition partially offset by lower amortization expenses related to the sale of its blood screening business. The company’s gross margin contracted from 64.07% in fiscal 2017 to 62.72% in fiscal 2018.
Mon, 26 Nov 2018
14:30:12 +0000
How Hologic’s Revenue Is Trending
Hologic (HOLX) is a leading developer, manufacturer, and supplier of diagnostics products, medical imaging systems, surgical products, and treatment systems. The company operates in five segments: diagnostics, breast health, medical aesthetics, GYN surgical, and skeletal health.
Fri, 23 Nov 2018
13:15:00 +0000
Hologic to Showcase Growing Portfolio of Breast and Skeletal Health Innovations at RSNA 2018
Hologic, Inc. (HOLX) will showcase its expanding suite of breast and skeletal health products, including screening, interventional, ultrasound and surgical solutions, in Booth #2511 at the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place in Chicago from Nov. 25 to 29. The pioneer behind the Genius™ 3D Mammography™ exam, Hologic has expanded significantly in recent years to offer innovations across the entire clinical continuum of breast health. In addition, two recent acquisitions of Faxitron® Bioptics, a leader in digital specimen radiography, and Focal Therapeutics, manufacturer of the BioZorb® marker, have enabled Hologic to play a larger role in breast conserving surgery and strengthened its offerings to radiologists, pathologists and breast surgeons.
Wed, 21 Nov 2018
13:16:21 +0000
3 Big Stock Charts for Wednesday: Coca-Cola, Hologic and Applied Materials
Mon, 19 Nov 2018
21:03:00 +0000
Ludwig N. Hantson Elected to Hologic Board of Directors
Hologic, Inc. (HOLX) announced today that Ludwig N. Hantson has been elected to the Company’s Board of Directors, effective immediately. Dr. Hantson, who has more than 30 years of experience in the life sciences industry, is the Chief Executive Officer of Alexion Pharmaceuticals, Inc., a publicly-traded global biopharmaceutical company. Before joining Alexion, Dr. Hantson was President and Chief Executive Officer of Baxalta Incorporated.
Fri, 16 Nov 2018
21:05:00 +0000
Hologic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference
Hologic, Inc. announced today that the Company will present at the 30th Annual Piper Jaffray Healthcare Conference in New York, NY on Wednesday, November 28 at 8 a.m.
Thu, 08 Nov 2018
22:57:00 +0000
Edited Transcript of HOLX earnings conference call or presentation 7-Nov-18 9:30pm GMT
Q4 2018 Hologic Inc Earnings Call
Thu, 08 Nov 2018
15:39:03 +0000
Hologic (HOLX) Q4 Earnings Miss, Revenues Top Estimates
Tough year-over-year comparisons and soft Diagnostics sales hurt Hologic's (HOLX) performance in Q4.
Thu, 08 Nov 2018
05:07:20 +0000
Hologic, Inc. (HOLX) Q4 2018 Earnings Conference Call Transcript
HOLX earnings call for the period ending September 30, 2018.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This is the most knowledgable group I've ever been associated with (23 years). It is also the most unselfish and there is never any name calling or putting members down. ValueForum has helped me be very successful." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards